Alyeska Investment Group
CRMD icon

Alyeska Investment Group’s CorMedix CRMD Stock Holding History

Alyeska Investment Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.77M Hold
850,000
– – 0.02% 458
2025
Q4 		$9.89M Sell
850,000
-412,979
-33% -$4.57M 0.03% 392
2025
Q3 		$14.7M Buy
1,262,979
+512,979
+68% +$6.2M 0.04% 330
2025
Q2 		$9.24M Buy
+750,000
New +$8.28M 0.03% 368
2023
Q4 		– Sell
-150,000
Closed -$555K – 545
2023
Q3 		$555K Sell
150,000
-850,000
-85% -$3.38M ﹤0.01% 443
2023
Q2 		$3.96M Buy
+1,000,000
New +$4.95M 0.03% 356

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Alyeska Investment Group's CRMD Position: Q1 2026 in Review

Alyeska Investment Group held its CorMedix (CRMD) position steady in Q1 2026 at 850,000 shares worth $5.77M. The position accounts for 0.02% of the portfolio, ranked #458.

Alyeska Investment Group first reported a position in CRMD in Q2 2023 and has held it in 6 quarters since. The position peaked at $14.7M in Q3 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Alyeska Investment Group held 850,000 shares of CorMedix worth $5.77M as of Q1 2026.
  • Alyeska Investment Group left its CorMedix share count unchanged in Q1 2026.
  • CorMedix made up 0.02% of Alyeska Investment Group's portfolio in Q1 2026, its #458 holding.
  • Alyeska Investment Group first reported a position in CorMedix in Q2 2023 and has held it in 6 quarters since.
  • Alyeska Investment Group's CorMedix position peaked at $14.7M in Q3 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.